BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11940548)

  • 1. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.
    Ehsan A; Mann MJ; Dell'Acqua G; Tamura K; Braun-Dullaeus R; Dzau VJ
    Circulation; 2002 Apr; 105(14):1686-92. PubMed ID: 11940548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
    Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
    Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
    J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.
    Ohno N; Itoh H; Ikeda T; Ueyama K; Yamahara K; Doi K; Yamashita J; Inoue M; Masatsugu K; Sawada N; Fukunaga Y; Sakaguchi S; Sone M; Yurugi T; Kook H; Komeda M; Nakao K
    Circulation; 2002 Apr; 105(14):1623-6. PubMed ID: 11940536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates.
    Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M
    Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
    Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F decoy oligonucleotide for genetic engineering of vascular bypass grafts.
    Mann MJ
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):171-6. PubMed ID: 9593059
    [No Abstract]   [Full Text] [Related]  

  • 13. Local application of paeonol prevents early restenosis: a study with a rabbit vein graft model.
    Zhang JY; Lei L; Shang J; Huo TM; Zhang B; Chen G; Zeng ZY; Li SK
    J Surg Res; 2017 May; 212():278-287. PubMed ID: 28550918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
    Miyake T; Aoki M; Morishita R
    Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
    Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK
    Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling 3 is a negative regulator for neointimal hyperplasia of vein graft stenosis.
    Xiang S; Liu J; Dong N; Shi J; Xiao Y; Wang Y; Hu X; Gong L; Wang W
    J Vasc Res; 2014; 51(2):132-43. PubMed ID: 24685947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS
    J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration.
    O'Blenes SB; Zaidi SH; Cheah AY; McIntyre B; Kaneda Y; Rabinovitch M
    Circulation; 2000 Nov; 102(19 Suppl 3):III289-95. PubMed ID: 11082403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.